Impact of supplementary immunization activities in measles-endemic areas: A case study from Guangxi, China

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 1, 2011, Pages

  Zhuo, Jiatong ^a   Geng, Wenkui ^b   Hoekstra, Edward J ^c   Zhong, Ge ^a   Liang, Xiaofeng ^d   Zhang, Jian ^e  

^a Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention   (China)

^b Department of Research and Education Management   (China)

^c Health Section   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e GEORGIA SOUTHERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ADOLESCENT; CASE STUDY; CHILD; CHINA; CLINICAL EFFECTIVENESS; EPIDEMIC; FEASIBILITY STUDY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; TREND STUDY; ARTICLE; ENDEMIC DISEASE; IMMUNIZATION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SOCIOECONOMICS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; ENDEMIC DISEASES; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; MEASLES; MEASLES VACCINE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 79960875939     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir063     Document Type: Review

References (47)

1. Progress toward the 2012 measles elimination goal-Western Pacific Region, 1990-2008. MMWR Morb Mortal Wkly Rep 2009; 58:669-73.
2. Yang Z, Zhang J, Zhang X. Classification of measles control situation in different areas of China [in Chinese] Zhonghu Liu Xing Bing Xue Za Zhi (Chinese J Epidemiol) 1998; 19:84-8.
3. Lixia W, Guang Z, Lee LA, et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis 2003; 187(suppl 1);S252-7.
4. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World population prospects: the 2008 revision, highlights. http://esa.un.org/unpd/wpp2008/peps-documents.htm. Published 2009. Accessed 1 June 2009.
5. Provincial Government of Guangxi. Demographic fact sheet-Guangxi Zhuang autonomous regions. The gateway of Guangxi Zhuang Automonous Regions, 2009. http://www.gxzf.gov.cn/gxzf-gxgk/gxgk-rk/index.htm. Accessed 1 September 2009.
6. Bureau of Statistics of China. China statistical yearbook, 2008. Beijing: China Statistics Press, 2008; 49-59.
7. Zhuo JT, Yang H, Wang S. Measles surveillance in a rural area: assessment of a passive reporting system [in Chinese. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese J Epidemiol) 1994; 15:203-5.
8. Zhuo J, Zhong G, Zg ZG. Research and primary application on identifying measles high-risk counties with historic epidemic curve interval. Chin J Vaccines Immunization 2006; 12:486-8.
9. Zhuo JT. The operation models of Expanded Program of Immunization in poor areas in Guangxi. Chin J Vaccines Immunization 2005; 11:309-13.
10. Zhang J, Yu JJ, Zhang RZ, et al. Costs of polio immunization days in China: implications for mass immunization campaign strategies. Int J Health Plann Manage 1998; 13:5-25.
11. Zhuo JT, Yang H, Wang S. The reason of measles resurgence in the mountainous area in Guangxi and its control strategy [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese J Epidemiol) 2009; 30:384-90.
12. Biellik R, Madema S, Taole A, et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002; 359:1564-8.
13. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. MMWR Recomm Rep 1997; 46:1-20.
14. Zeng G, Zhang JK, Rou KM, Xu C, Cheng YK, Qi GM. Infectious disease surveillance in China. Biomed Environ Sci 1998; 11:31-7.
15. Zhang J, Wang KA, Yang ZW, Zhang RZ, Zhang XL, Yu JJ. Evaluation on effectiveness and role of the mass immunization campaign. Chin J Vaccines Immunization 1997; 3:14-6.
16. Zhuo JT, Zhong G, Liu W, Zheng ZG, Hoekstra EZJ. Innovative use of surveillance data to harness political will to accelerate measles elimination: experience from Guangxi, China. J Infect Dis 2010.
17. Bolker BM, Grenfell BT. Chaos and biological complexity in measles dynamics. Proc Biol Sci 1993; 251:75-81.
18. United Nations Children's Fund. Plan of action for implementing the world declaration on the survival, protection and development of children in the 1990s. New York, New York: United Nations Children's Fund, 1990.
19. World Health Assembly. Handbook of resolutions and decisions of the World Health Assembly and the Executive Board. Geneva, Switzerland: World Health Organization, 1990.
20. Elliman D, Bedford H. Achieving the goal for global measles mortality. Lancet 2007; 369:165-6.
21. World Health Organization. Child health in the community: "Community IMCI"-briefing package for facilitators. http://www.who.int/child- adolescent-health/documents/9241591951/en/index.html. Accessed 9 June 2009.
22. Strebel P, Cochi S, Grabowsky M, et al. The unfinished measles immunization agenda. J Infect Dis 2003; 187(suppl 1):S1-7.
23. de Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G. Progress toward measles eradication in the region of the Americas. J Infect Dis 2003; 187(suppl 1);S102-10.
24. Hinman AR, Orenstein WA, Papania MJ. Evolution of measles elimination strategies in the United States. J Infect Dis 2004; 189(suppl 1);S17-22.
25. Henao-Restrepo AM, Strebel P, John HE, Birmingham M, Bilous J. Experience in global measles control, 1990-2001. J Infect Dis 2003; 187(suppl 1);S15-21.
26. Ministry of Health of China. National Plan for Accelerated Measles Control, 2006-2012. DC(2006-441).
27. Provincial Department of Health, Guangxi, China. Strengthen the leadership creating novel strategies for a new stage of immunization service-documents for 2008 national conference of disease control and prevention. 2008. http://www.moh.gov.cn/uploadfile/2006426143458739.doc. Accessed 9 September 2009.
28. Youwang Y, Ping W, Feng C. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months. Vaccine 2001; 19:1998-2005.
29. Zhuo JT, Liu W, Zhong G, et al. Measles antibody level among children 8 months to 4 years in Gaungxi Zhuang Autonomous Region. Chin J Vaccines Immunization 2009; 11:21-3.
30. Zhuo JT. Strategies and measures for four bottle-necks on planned immunity in Guangxi. Chin J Vaccines Immunization 2005; 11:224-33.
31. Zhuo JT. Social mobilization and its outcome during EPI field supervision in depressed and remote rural areas in Guangxi. Chin J Vaccines Immunization 2008; 24:582-5.
32. Otten MW Jr., Okwo-Bele JM, Kezaala R, Biellik R, Eggers R, Nshimirimana D. Impact of alternative approaches to accelerated measles control: experience in the African region, 1996-2002. J Infect Dis 2003; 187(suppl 1);S36-43.
33. Cliff J, Simango A, Augusto O, Van Der PL, Biellik R. Failure of targeted urban supplemental measles vaccination campaigns (1997-1999) to prevent measles epidemics in Mozambique (1998-2001). J Infect Dis 2003; 187(suppl 1));S51-7.
34. Hitchen L. London's catch-up vaccination campaign against measles, mumps, and rubella reaches less than a quarter of children who were unvaccinated. BMJ 2008; 337:a1797.
35. Wang KA, Zhang J, Zhang RZ, et al. Retrospective and prospective of mass immunization campaign. Chin J Vaccines Immunization 1997; 3:5-8.
36. Zhang J, Zhang LB, Otten MW Jr., et al. Surveillance for polio eradication in the People's Republic of China. J Infect Dis 1997; 175(suppl 1);S122-34.
37. Janes GR, Hutwagner LC, Cates W Jr., Stroup DF, Williamson GD. Descriptive epidemiology: analyzing and interpreting surveillance data. In Teutsch SM, Churchill RE eds: Principles and practice of public health surveillance. New York: Oxford University Press, 2000; 112-67.
38. Liang WN, Zhao T, Liu ZJ, et al. Severe acute respiratory syndrome-retrospect and lessons of 2004 outbreak in China. Biomed Environ Sci 2006; 19:445-51.
39. Majdzadeh R, Moradi A, Zeraati H, Sepanlou SG, Zamani G, Zonobi V. Evaluation of the measles-rubella mass vaccination campaign in the population covered by Tehran University of Medical Sciences. East Mediterr Health J 2008; 14:810-7.
40. Munyoro MN, Kufa E, Biellik R, Pazvakavambwa IE, Cairns KL. Impact of nationwide measles vaccination campaign among children aged 9 months to 14 years, Zimbabwe, 1998-2001. J Infect Dis 2003; 187(suppl 1);S91-6.
41. Nanyunja M, Lewis RF, Makumbi I, et al. Impact of mass measles campaigns among children less than 5 years old in Uganda. J Infect Dis 2003; 187(suppl 1));S63-8.
42. Murakami H, Van CN, Van TH, Tsukamoto K, Hien dS. Epidemiological impact of a nationwide measles immunization campaign in Viet Nam: a critical review. Bull World Health Organ 2008; 86:948-55.
43. Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran. Int J Infect Dis 2008; 12:43-6.
44. Takechi M, Matsuo M, Butao D, Zungu IL, Chakanika I, Michongwe J. Measles sero-surveillance during mass immunisation campaign in Malawi. East Afr Med J 2001; 78:4-8.
45. Ohuma EO, Okiro EA, Bett A, et al. Evaluation of a measles vaccine campaign by oral-fluid surveys in a rural Kenyan district: interpretation of antibody prevalence data using mixture models. Epidemiol Infect 2009; 137:227-33.
46. Kuroiwa C, Xayyavong P, Vongphrachanh P, Khampapongpane B, Yamanaka M, Nakamura S. Difficulties in measles elimination: prevalence of measles antibodies before and after mass vaccination campaign in Laos. Vaccine 2003; 21:479-84.
47. Zhuo JT, Liu W, Zhong G, Zheng ZG, Wang HT, Xie ZG. Evaluation of the strategy to identify high risk counties in Guangxi Zhuangzu autonomous region and implementation of catch-up immunization for measles control. Chin J Vaccines Immunization 2004; 10:76-8.